Table 1 Patients characteristics
From: Age and sex corrected normal reference values of T1, T2 T2* and ECV in healthy subjects at 3T CMR
Total population n = 75 | [20–30] n = 10 | [30-40] n = 9 | [40-50] n = 9 | [50-60] n = 11 | [60-70] n = 11 | [70-80] n = 20 | >or = 80 n = 5 | P value | |
|---|---|---|---|---|---|---|---|---|---|
Age (years) | 56 ± 19 | 26 ± 3 | 36 ± 3 | 45 ± 3 | 55 ± 3 | 64 ± 3 | 74 ± 3 | 84 ± 5 | <0.001 |
Weight (kg) | 71 ± 13 | 66 ± 11 | 75 ± 13 | 71 ± 10 | 71 ± 12 | 75 ± 16 | 69 ± 11 | 74 ± 18 | 0.63 |
Height (m) | 1.71 ± 0.08 | 1.76 ± 0.06 | 1.76 ± 0.06 | 1.72 ± 0.07 | 1. 68 ± 0.08 | 1.75 ± 0.07 | 1.65 ± 0.07 | 1.68 ± 0.10 | 0.04 |
BMI (kg/m2) | 24 ± 4 | 21 ± 2 | 24 ± 4 | 24 ± 3 | 25 ± 4 | 24 ± 4 | 25 ± 3 | 26 ± 5 | 0.12 |
BSA (m2) | 1,8 ± 0,2 | 1.8 ± 0.2 | 1,9 ± 0,2 | 1,8 ± 0,1 | 1,8 ± 0,2 | 1,9 ± 0,2 | 1,8 ± 0,2 | 1,8 ± 0,3 | 0.31 |
Sex (Female) | 36 (48%) | 4 (40%) | 2 (22%) | 4 (44%) | 5 (45%) | 4 (36%) | 14 (70%) | 3 (60%) | 0.27 |
SBP (mmHg) | 133 ± 20 | 120 ± 17 ε | 122 ± 20ε | 126 ± 12 | 136 ± 12 | 133 ± 14 | 145 ± 23†¥ | 144 ± 17 | 0.003 |
HR (bpm) | 67 ± 10 | 67 ± 9 | 68 ± 7 | 67 ± 11 | 67 ± 15 | 69 ± 9 | 68 ± 9 | 63 ± 8 | 0.95 |
GFR (ml/min/1.73m2) | 77 ± 16 | 88 ± 19 ε◊ | 88 ± 11$ε◊ | 80 ± 12 | 76 ± 8 | 70 ± 9¥ | 72 ± 19†¥ | 66 ± 12†¥ | 0.006 |
Hematocrit (%) | 42 ± 3 | 43 ± 3 | 44 ± 2 | 41 ± 2 | 42 ± 3 | 42 ± 2 | 42 ± 5 | 39 ± 2 | 0.71 |
Ferritin (μg/l) | 120 [15;619] | 167 [35;294] | 118 [26;591] | 129 [28;257] | 129 [21;196] | 115 [15;182] | 126 [16;619] | 104 [54;126] | 0.64 |
Smoking (%) | 9 (12%) | 0 (0%) | 0 (0%) | 1 (11%) | 0 (0%) | 2 (18%) | 5 (25%) | 1 (20%) | 0.26 |
Hypertension (%) | 19 (25%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (9%) | 2 (18%) | 10 (50%) | 5 (100%) | 0.001 |
Hypercholesterolemia (%) | 46 (60%) | 2 (20%) | 2 (22%) | 4 (44%) | 8 (73%) | 7 (64%) | 18 (90%) | 4 (80%) | 0.001 |
Family history of CAD (%) | 10 (13%) | 1 (10%) | 3 (33%) | 0 (0%) | 2 (18% | 1 (9%) | 1 (5%) | 1 (20%) | 0.19 |